Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alpine Immune Sciences Inc (NQ: ALPN )

9.840 USD +0.780 (+8.61%)
Official Closing Price Updated: 2:53 PM EST, Nov 27, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 102,900
Open 9.290
Bid (Size) 9.000 (10)
Ask (Size) 9.930 (2)
Prev. Close 9.060
Today's Range 9.289 - 10.13
52wk Range 2.050 - 15.00
Shares Outstanding 13,849,562
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Alpine Immune Sciences to Participate in Fireside Chat at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
Alpine Immune Sciences to Participate in Fireside Chat at the Evercore ISI 3rd Annual HealthCONx Virtual Conference 
From Business Wire News Releases
Alpine Immune Sciences to Participate in Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Alpine Immune Sciences to Participate in Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference 
From Business Wire News Releases

Performance

YTD
+171.58%
+171.58%
1 Month
+31.20%
+31.20%
3 Month
+20.59%
+20.59%
6 Month
+153.37%
+153.37%
1 Year
+227.45%
+227.45%

More News

Read More
Alpine Immune Sciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update
From Business Wire News Releases
Alpine Immune Sciences to Report Third Quarter 2020 Financial Results and Provide Corporate Update
From Business Wire News Releases
Alpine Immune Sciences to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
From Business Wire News Releases
Alpine Immune Sciences to Present at H.C. Wainwright 22nd Annual Global Investment Conference
From Business Wire News Releases
Alpine Immune Sciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update
From Business Wire News Releases
Alpine Immune Sciences to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
From Business Wire News Releases
Alpine Immune Sciences to Report Second Quarter 2020 Financial Results and Provide Corporate Update
From Business Wire News Releases
Alpine Immune Sciences Announces $60 Million Private Placement
From Business Wire News Releases
Alpine Immune Sciences Announces First Patient Dosed in NEON-1 Phase 1 Trial of ALPN-202 in Patients with Advanced Malignancies
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.